Inhalation powder formulations containing enantiomerically pure beta-agonists

Details for Australian Patent Application No. 2005244424 (hide)

Owner Boehringer Ingelheim International GmbH

Inventors Schiewe, Joerg; Trunk, Michael

Agent Davies Collison Cave

Pub. Number AU-B-2005244424

PCT Pub. Number WO2005/110359

Priority 10 2004 024 451.0 14.05.04 DE

Filing date 11 May 2005

Wipo publication date 24 November 2005

Acceptance publication date 23 December 2010

International Classifications

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 31/538 (2006.01)

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

Event Publications

7 December 2006 PCT application entered the National Phase

  PCT publication WO2005/110359 Priority application(s): WO2005/110359

23 December 2010 Application Accepted

  Published as AU-B-2005244424

21 April 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005244425-Identification of surface-associated antigens for tumor diagnosis and therapy

2005244423-Fungicide mixtures based on a triazolopyrimidine derivative